C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/54 (2006.01) A61K 38/20 (2006.01) C12N 15/24 (2006.01) C12N 15/861 (2006.01)
Patent
CA 2609543
IL-10 sequence variants are disclosed that retain the therapeutically desirable anti-inflammatory properties of wild-type IL-10 but do not retain the hemoatopoeitic cell regulatory and cell proliferative activities. The mutant IL-10 polypeptides of the invention are used in methods of treating diseases involving inflammatory response, including neuropathic pain and other neurological disorders.
L'invention concerne des variants de séquence d'IL-10 qui conservent les propriétés anti-inflammatoires désirées sur le plan thérapeutique de l'IL-10 de type sauvage sans conserver les activités de régulation des cellules hématopoïétiques et de prolifération cellulaire. Lesdits polypeptides d'IL-10 mutante sont utilisés dans des méthodes de traitement de maladies dans lesquelles la réponse inflammatoire est impliquée, de type douleur neuropathique et autres troubles neurologiques.
Chavez Raymond A.
Johnson Kirk W.
Sommer Jurg M.
Watkins Linda May Rothblum
Avigen Inc.
Smart & Biggar
The Regents Of The University Of Colorado
LandOfFree
Mutant il-10 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant il-10, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant il-10 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1685319